BiotechTube

Palonosetron 0.075 mg IV + Dexamethasone 10 mg IV + Promethazine 25 mg IV

ApprovedCompleted
0 watching 0 views this week🔥 Hot
85
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Postoperative Nausea and Vomiting

Conditions

Postoperative Nausea and Vomiting

Trial Timeline

Oct 1, 2009 → Oct 1, 2011

NCT ID
NCT02635828

About Palonosetron 0.075 mg IV + Dexamethasone 10 mg IV + Promethazine 25 mg IV

Palonosetron 0.075 mg IV + Dexamethasone 10 mg IV + Promethazine 25 mg IV is a approved stage product being developed by Eisai for Postoperative Nausea and Vomiting. The current trial status is completed. This product is registered under clinical trial identifier NCT02635828. Target conditions include Postoperative Nausea and Vomiting.

Hype Score Breakdown

Clinical
30
Activity
20
Company
10
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT02635828ApprovedCompleted

Competing Products

20 competing products in Postoperative Nausea and Vomiting

See all competitors
ProductCompanyStageHype Score
Naldemedine + PlaceboShionogiPhase 2
52
Lemborexant 5 mg + Control (placebo) groupEisaiPhase 2
52
Ondansetron + PalonosetronEisaiPhase 2
52
AQUAVAN (fospropofol disodium; GPI 15715 )EisaiPhase 2
52
ONO-1101Ono PharmaceuticalPhase 2
52
ONO-1101Ono PharmaceuticalPhase 2/3
65
Levofloxacin Ophthalmic + CefuroximeSanten PharmaceuticalPhase 1/2
41
Levofloxacin Ophthalmic Product + Moxifloxacin Ophthalmic SolutionSanten PharmaceuticalPhase 1/2
41
Bupivacaine Liposome Injection T preparation + Bupivacaine Liposome Injection R preparationJiangsu Hengrui MedicinePhase 1
33
SHR0410 Injection + SHR0410 Injection + PlaceboJiangsu Hengrui MedicinePhase 3
77
SHR8554 InjectionJiangsu Hengrui MedicinePhase 1
33
EsomeprazoleAstraZenecaApproved
85
deep neuromuscular blockMerckPre-clinical
23
Rolapitant Dose 1 + Rolapitant Dose 2 + Rolapitant Dose 3 + Rolapitant Dose 4 + Ondansetron + PlaceboMerckPhase 2
52
MK0966, rofecoxib + Comparator: valdecoxibMerckPhase 3
77
Aprepitant, Dexamethasone, Ondansetron + Aprepitant, Dexamethasone, PlaceboMerckApproved
85
MK0719MerckPhase 2
52
Sugammadex + NeostigmineMerckApproved
85
MK0869, aprepitant + Comparator: ondansetron IVMerckPhase 3
77
MK0869, aprepitant + Comparator: ondansetron IVMerckPhase 3
77

Other Products from Eisai

MecobalaminApproved
85
MonteplaseApproved
85
E2020 + PlaceboApproved
85
DonepezilApproved
85
Lemborexant (LEM) 5 mg (Z-Drug-mono cohort) + Lemborexant (LEM) 5 mg (SUV-mono cohort) + Lemborexant (LEM) 5 mg (SUV-combination cohort) + Lemborexant (LEM) 5 mg (RMT-combination cohort)Approved
85